课题基金 / 基金详情

Dietary protein, the microbiota and gut barrier function: a gatekeeper of metabolic & immune health

Dietary protein, the microbiota and gut barrier function: a gatekeeper of metabolic & immune health
膳食蛋白质、微生物群和肠道屏障功能:代谢的看门人
批准号:
2753835
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The gut barrier functions to prevent the passage of bacteria and bacterial products into the systemic blood circulation. If the gut barrier fails, bacterial products can infiltrate bodily tissues, causing metabolic and immune dysfunction. The best example of this effect occurs in inflammatory conditions that lead to a translocation of bacterial lipopolysaccharide (LPS) from the gut to the liver, where LPS has been implicated in promoting the accumulation of ectopic fat and non-alcoholic fatty liver disease, a common condition that contributes to the development of cardiovascular and terminal liver diseases. We have new evidence to show that gut barrier function, as measured by an increase in gut permeability, is also impaired in healthy men, a phenomenon known as 'leaky gut'. While there may be different causes of this condition, there is emerging evidence to suggest that the fermentation products of dietary protein may impair gut barrier function in the colon, especially in the absence of fermentable carbohydrate. If this link can be substantiated, it would have major implications for the over consumption of protein in the UK population, especially with respect to proposed dietary recommendations to increase protein intake in middle-aged adults.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对 话促进子宫腺肌病蜕膜化缺陷的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    吕海宁
  • 依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
  • 批准号:
    32372636
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    郭慧娟
  • 依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
  • 批准号:
    82371054
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郭涛
  • 依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    郑凌艳
  • 依托单位: